Long-term follow-up of children with carbamoyl phosphate synthase 1 deficiency detected in newborn screening.
10.3724/zdxbyxb-2023-0359
- Author:
Zhanming ZHANG
1
;
Fan TONG
2
;
Chi CHEN
2
;
Ting ZHANG
2
;
Guling QIAN
2
;
Xin YANG
2
;
Xinwen HUANG
2
;
Rulai YANG
2
;
Zhengyan ZHAO
3
Author Information
1. Department of Genetic and Metabolism,Children's Hospital,Zhejiang University School of Medicine,National Clinical Research Center for Child Health, Hangzhou 310052, China. chzzm@zju.edu.cn.
2. Department of Genetic and Metabolism,Children's Hospital,Zhejiang University School of Medicine,National Clinical Research Center for Child Health, Hangzhou 310052, China.
3. Department of Genetic and Metabolism,Children's Hospital,Zhejiang University School of Medicine,National Clinical Research Center for Child Health, Hangzhou 310052, China. zhaozy@zju.edu.cn.
- Publication Type:Journal Article
- Keywords:
Carbamyl phosphate synthetase 1 deficiency;
Follow-up studies;
Genotype;
Newborn screening;
Phenotype;
Prognosis
- MeSH:
Child;
Humans;
Infant, Newborn;
Carbamoyl-Phosphate Synthase I Deficiency Disease/therapy*;
Neonatal Screening;
Follow-Up Studies;
Hyperammonemia;
Citrulline/genetics*;
Retrospective Studies;
Mutation
- From:
Journal of Zhejiang University. Medical sciences
2023;52(6):721-726
- CountryChina
- Language:English
-
Abstract:
OBJECTIVES:To investigate genotype-phenotype characteristics and long-term prognosis of neonatal carbamoyl phosphate synthetase 1 (CPS1) deficiency among children through newborn screening in Zhejiang province.
METHODS:The clinical and follow-up data of children with CPS1 deficiency detected through neonatal screening and confirmed by tandem mass spectrometry and genetic testing in Zhejiang Province Newborn Disease Screening Center from September 2013 to August 2023 were retrospectively analyzed.
RESULTS:A total of 4 056 755 newborns were screened and 6 cases of CPS1 deficiency were diagnosed through phenotypic and genetic testing. Ten different variations of CPS1 genewere identified in genetic testing, including 2 known pathogenic variations (c.2359C>T and c.1549+1G>T) and 8 unreported variations (c.3405-1G>T, c.2372C>T, c.1436C>T, c.2228T>C, c.2441G>A, c.3031G>A, c.3075T>C and c.390-403del). All patients had decreased citrulline levels (2.72-6.21 μmol/L), and varying degrees of elevated blood ammonia. The patients received restricted natural protein intake (special formula), arginine and supportive therapy after diagnosis, and were followed-up for a period ranging from 9 months to 10 years. Three patients experienced hyperammonemia, and one patient each had attention deficit hyperactivity disorder, transient facial twitching and increased muscle tone. One patient died, while the other five surviving patients had normal scores of the Ages & Stages Questionnaires (ASQ) and Griffiths Development Scales up to the present time; 4 cases had combined height or weight lag and one case was normal in height and weight.
CONCLUSIONS:Low citrulline levels and hyperammonemia are common in CPS1 deficiency patients in Zhejiang. Most gene variants identified were specific to individual families, and no hotspot mutations were found. Early diagnosis through newborn screening and following standardized treatment can significantly improve the prognosis of the patients.
